Business NewsPR NewsWire • Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development

Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development

Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development

SEATTLE, Sept. 4, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC), a company focused on translating science into novel cancer therapies, today appointed former  Managing Director and Head of West Coast Biotechnology for Oppenheimer & Co. and its U.S....

View More : http://www.prnewswire.com/news-releases/cell-therapeutics-inc-cti-appoints-former-managing-director-head-of-west-coast-b...
Releted News by prnewswire
Frost & Sullivan: Australian Unified Communications Market to Generate Revenues exceeding $1b by 2016
Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
Radon Mitigation Company, S.W.A.T. Environmental Makes Inc. Magazine List of Fastest Growing Companies